Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Formulated with 0.9% benzyl alcohol (9 mg/mL) as a bacteriostatic preservative, it helps inhibit microbial growth, making it ideal for repeated withdrawals when proper sterile technique is followed
Comparative studies of single-peptide versus multi-peptide activity on fibroblast migration, proliferation, and ECM organization
At Mirror Plastic Surgery, BPC-157 is often included in the Glow Stack with TB500 and GHK-CU to support inflammation control and tissue repair
Net Peptide Content Explained for Research MaterialsHow net peptide content differs from chromatographic purity on research-material documentation: counter-ions, residual moisture, assay basis, and what to archive research use only
| | Intensive Performance Protocol | 10mg subcutaneous, 5x/week (weekdays) | 150mg oral, daily | Both compounds AM, pre-training | 6 weeks on, 4 weeks off | Athletic performance research, substrate utilization studies, endurance capacity trials | Higher dosing frequency and dose intensity produce more pronounced short-term shifts in RER and VO2 max, but require stricter adherence and increase washout sensitivity
metabolite Ac-LKKTE identified as potentially more active than parent compound Paradoxical finding: Both peptides show biological effects persisting hours to days after administration despite rapid plasma clearance Possible explanations: Tissue retention, active metabolites, or persistent signaling cascade activation Excretion Pathways Limited data exists on excretion for both peptides[22]: Likely renal elimination of peptide fragments Hepatic metabolism may contribute to clearance No accumulation detected in chronic dosing studies (animal models) Combined excretion kinetics have not been characterized in any species The disconnect between short plasma half-lives and prolonged biological effects represents a key area requiring mechanistic clarification for both individual peptides and their combination
